Radius Health Announces Fourth Quarter and Full-Year 2018 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Radius Health (RDUS) Tops Q4 EPS by 51c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Below Consensus
February 28, 2019 4:30 PM ESTRadius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.66), $0.51 better than the analyst estimate of ($1.17). Revenue for the quarter came in at $34.4 million versus the consensus estimate of $33.01 million.
I am very pleased with the continued strong performance of TYMLOS in the U.S.... More
